You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022174016
Dec 20224807
Jan 20234204
Feb 20233209
Mar 20233404
Apr 20231801
May 20232407
Jun 2023201
Jul 20232005
Aug 2023802
Sep 20232001
Oct 20231001
Nov 20232803
Dec 20233805
Jan 20243004
Feb 20242403
Mar 202438018
Apr 20243003
May 20244207
Jun 20241804
Jul 20241806
Aug 20243406
Total7320117